tAN for Substance Use Disorder
RecruitingNCT07281261Phase: NAStarted 2026-01-28
Summary
The study will involve a 5-day tAN treatment to attenuate alcohol withdrawal syndrome (AWS) and alter resting state functional connectivity (RSFC) between OFC and striatum in patients with alcohol use
Eligibility
Sex
ALL
Min Age
18 Years
Max Age
64 Years
Locations
The Menninger ClinicHouston, Texas, United States
View full study details on ClinicalTrials.gov
clinicaltrials.gov/study/NCT07281261